About Teduglutide
            
            Class: | Glucagon-like peptide-2 (GLP-2) analog  
Use: | Treatment of short bowel syndrome (SBS) in patients who are dependent on parenteral support  
Adult dose: | 0.05 mg/kg subcutaneously once daily, may be increased to 0.1 mg/kg based on clinical response  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Abdominal pain, nausea, headache, injection site reactions, diarrhea  
Contraindications: | History of hypersensitivity to teduglutide or any co
         
        
            
                
                
                    
                        Drug Class
                    
                    Glucagon-like peptide-2 (GLP-2) analog
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of short bowel syndrome (SBS) in patients who are dependent on parenteral support
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator (2°C to 8°C or 36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: SHIRE PHARMACEUTICALS IRELAND LIMITED, IRELAND
                    
                    
                    Package Size
                    Vial x 28
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 94875.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        0.05 mg/kg subcutaneously once daily, may be increased to 0.1 mg/kg based on clinical response
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Abdominal pain, nausea, headache, injection site reactions, diarrhea
                 
             
         
        
        
            
                Contraindications & Precautions
            
            History of hypersensitivity to teduglutide or any component of the formulation; patients with active gastrointestinal obstruction
         
        
        
            
                Important Warnings
            
            Risk of intestinal obstruction; monitor for signs of obstruction; may cause increased risk of neoplasms; use caution in patients with a history of malignancy
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.